⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Regeneron Pharmaceuticals, Inc. (REGN) Investors of September 14, 2026 Deadline
accessnewswire.com
REGN
Pomerantz LLP Advises Investors of Class Action Involving Regeneron Pharmaceuticals, Inc. – REGN
accessnewswire.com
REGN
Pomerantz LLP Advises Shareholders of Class Action Filing Involving Regeneron Pharmaceuticals, Inc. – REGN
accessnewswire.com
REGN
$REGN Stock Alert: Regeneron Securities Class Action Filed After 9% Stock Drop Tied to Clinical Trials - September 14 Lead Plaintiff Deadline
accessnewswire.com
REGN
Pomerantz LLP Advises Investors of Class Action Filing Involving Regeneron Pharmaceuticals, Inc. – REGN
accessnewswire.com
REGN
Investors in Regeneron Pharmaceuticals, Inc. (REGN): Protect Your Rights - Contact Levi & Korsinsky Before September 14, 2026
accessnewswire.com
REGN
Investors Urged to Contact Levi & Korsinsky For Information Before September 14, 2026 - Regeneron Pharmaceuticals, Inc. (REGN)
accessnewswire.com
REGN
$REGN Securities: Regeneron Investors have Rights in Pending Securities Fraud Class Action - Court Deadline is September 14
accessnewswire.com
REGN
Regeneron Pharmaceuticals, Inc. (REGN) Faces Securities Class Action Amid Disclosures About Key Trial’s Protocol and Ultimate Failure - HBSS
globenewswire.com
REGN
Lost Money on Regeneron Pharmaceuticals, Inc. (REGN)? Urged to Join Class Action Before September 14, 2026 - Contact Levi & Korsinsky
accessnewswire.com
REGN